Engineered macroscale cardiac constructs elicit human myocardial tissue-like functionality
Visualitza/Obre
10.1016/j.stemcr.2019.05.024
Inclou dades d'ús des de 2022
Cita com:
hdl:2117/170173
Tipus de documentArticle
Data publicació2019-07-09
Condicions d'accésAccés obert
Llevat que s'hi indiqui el contrari, els
continguts d'aquesta obra estan subjectes a la llicència de Creative Commons
:
Reconeixement-NoComercial-SenseObraDerivada 3.0 Espanya
Abstract
In vitro surrogate models of human cardiac tissue hold great promise in disease modeling, cardiotoxicity testing, and future applications in regenerative medicine. However, the generation of engineered human cardiac constructs with tissue-like functionality is currently thwarted by difficulties in achieving efficient maturation at the cellular and/or tissular level. Here, we report on the design and implementation of a platform for the production of engineered cardiac macrotissues from human pluripotent stem cells (PSCs), which we term “CardioSlice.” PSC-derived cardiomyocytes, together with human fibroblasts, are seeded into large 3D porous scaffolds and cultured using a parallelized perfusion bioreactor with custom-made culture chambers. Continuous electrical stimulation for 2 weeks promotes cardiomyocyte alignment and synchronization, and the emergence of cardiac tissue-like properties. These include electrocardiogram-like signals that can be readily measured on the surface of CardioSlice constructs, and a response to proarrhythmic drugs that is predictive of their effect in human patients.
CitacióValls, M. [et al.]. Engineered macroscale cardiac constructs elicit human myocardial tissue-like functionality. "Stem Cell Reports", 9 Juliol 2019, vol. 13, núm. 1, p. 207-220.
ISSN2213-6711
Fitxers | Descripció | Mida | Format | Visualitza |
---|---|---|---|---|
PIIS2213671119301924.pdf | 3,535Mb | Visualitza/Obre |